In addition, breast cancer and neuroblastoma cell line experiments showed that inhibition of HMGA1 reduces the performance of pErk, affecting tumor cell proliferation, migration, and invasion, and increasing apoptosis [46,47]. This evidence concerns the gene HMGA1 and breast carcinoma.